For years, a cancer diagnosis often meant facing two battles: the disease itself, and the financial toxicity of the cure.
Advanced immunotherapies like Nivolumab (globally known as Opdyta or Opdivo) changed the way we treat cancers like lung, kidney, and head & neck cancer. By unmasking cancer cells so the body’s own immune system can attack them, these drugs offered hope where chemotherapy failed.
But this hope came with a staggering price tag—often costing lakhs of rupees per dose. For many Indian families, this life-saving treatment was simply out of reach.
That changes now.
With the launch of Tishtha, Zydus Lifesciences has introduced the world’s first biosimilar of Nivolumab in India. It promises the same efficacy as the innovator drug but at a fraction of the cost.
At Medfast, we are proud to be at the forefront of this shift, making this breakthrough affordable and accessible to patients across the country.
The Tishtha Revolution: What Is It?
Tishtha injection is a biosimilar. This means it is highly similar to the reference biologic (Opdyta) in terms of safety, purity, and potency.
- Molecule: Nivolumab (PD-1 Inhibitor).
- Mechanism: It blocks the PD-1 protein on immune cells. This removes the “brakes” from the immune system, allowing T-cells to identify and destroy cancer cells.
- Manufacturer: Zydus Lifesciences, a trusted name in Indian oncology.
Breaking the Cost Barrier: Tishtha vs. Opdyta
The biggest headline here is the Nivolumab price in India.
Until now, the cost of a single cycle of immunotherapy could run into lakhs. Zydus has disrupted this market by pricing Tishtha significantly lower—making it a true cheaper alternative to Opdyta (Opdivo).
Estimated Price Impact:
- Tishtha 40mg: Launched at approximately ₹13,950 per vial.
- Tishtha 100mg: Launched at approximately ₹28,950 per vial.
Note: Prices are subject to change. Always check Medfast.net for the latest live rates.
This price reduction (roughly 1/4th the cost of the innovator) means that a treatment that was once a luxury is now a viable option for thousands of middle-class families.
Why Buy Tishtha from Medfast?
Even with lower prices, safety remains the priority. Nivolumab is a temperature-sensitive biological drug.
When you buy nivolumab online or buy Tishtha 40mg from Medfast, you get three non-negotiable guarantees:
- Strict Cold Chain Adherence: Tishtha must be stored between 2°C and 8°C. We use specialized thermal packaging to ensure that the medicine you receive is as potent as the day it left the store.
- Genuine Stock: We source directly from Zydus distributors. No middlemen, no risk of counterfeits. You receive the authentic hologram-sealed pack every time.
- Pan-India Delivery: Whether you are in a metro like Delhi or a smaller town, our logistics network ensures timely delivery so your treatment schedule is never delayed.
FAQs
Q: Is Tishtha as effective as Opdyta?
Yes. Tishtha is a “biosimilar,” which means it has undergone rigorous clinical trials to prove it matches the innovator drug in terms of safety and efficacy.
Q: What cancers is Tishtha used for?
It is indicated for the same cancers as Nivolumab: Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (Kidney Cancer), and Head & Neck Cancers.
Q: Do I need a prescription to buy Tishtha 40mg / 100mg?
Yes. This is a Schedule H prescription drug and must be administered under the supervision of an oncologist.
Q: How can I check the latest price?
Search for “Tishtha” on Medfast.net or upload your prescription to get a quote instantly.
Final Thoughts
The launch of Tishtha is more than just a new product; it is a victory for patient access. It proves that world-class cancer care doesn’t have to bankrupt a family.
If your doctor has prescribed Nivolumab, you now have an affordable choice.
Buy Tishtha 100mg from Medfast today—because your focus should be on fighting cancer, not fighting bills.
